BioLife Solutions (BLFS) Short Interest Ratio & Short Volume $23.26 +0.51 (+2.24%) Closing price 07/3/2025 03:36 PM EasternExtended Trading$23.68 +0.41 (+1.78%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioLife Solutions Short Interest DataBioLife Solutions (BLFS) has a short interest of 4.36 million shares, representing 9.39% of the float (the number of shares available for trading by the public). This marks a -6.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 419,764 shares to cover all short positions.Current Short Interest4,360,000 sharesPrevious Short Interest4,680,000 sharesChange Vs. Previous Month-6.84%Dollar Volume Sold Short$96.05 millionShort Interest Ratio7.3 Days to CoverLast Record DateJune 15, 2025Outstanding Shares47,500,000 sharesShort Percent of Float9.39%Today's Trading Volume503,412 sharesAverage Trading Volume419,764 sharesToday's Volume Vs. Average120% Short Selling BioLife Solutions? Sign up to receive the latest short interest report for BioLife Solutions and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLFS Short Interest Over TimeBLFS Days to Cover Over TimeBLFS Percentage of Float Shorted Over Time BioLife Solutions Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20254,360,000 shares $96.05 million -6.8%9.4%7.3 $22.03 5/31/20254,680,000 shares $102.16 million +12.5%10.3%8.3 $21.83 5/15/20254,160,000 shares $91.48 million +5.6%9.2%7.8 $21.99 4/30/20253,940,000 shares $94.99 million +2.9%N/A8 $24.11 4/15/20253,830,000 shares $85.91 million +7.0%8.4%8.9 $22.43 3/31/20253,580,000 shares $81.77 million +3.2%7.9%9.6 $22.84 3/15/20253,470,000 shares $86.75 million +2.1%7.6%11.4 $25.00 2/28/20253,400,000 shares $81.60 million +0.9%7.5%11.4 $24.00 2/15/20253,370,000 shares $93.58 million +3.1%7.4%11 $27.77 1/31/20253,270,000 shares $89.30 million -1.5%N/A8.8 $27.31 Get the Latest News and Ratings for BLFS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. 1/15/20253,320,000 shares $88.68 million +0.3%N/A8.8 $26.71 12/31/20243,310,000 shares $85.93 million +5.8%N/A8.7 $25.96 12/15/20243,130,000 shares $83.57 million -3.4%N/A8.1 $26.70 11/30/20243,240,000 shares $89.00 million +20.9%N/A8.4 $27.47 11/15/20242,680,000 shares $56.33 million -23.4%N/A7 $21.02 10/31/20243,500,000 shares $81.90 million -2.2%N/A11.4 $23.40 10/15/20243,580,000 shares $83.92 million +0.9%N/A11.2 $23.44 9/30/20243,550,000 shares $88.89 million -1.4%N/A10.7 $25.04 9/15/20243,600,000 shares $90.43 million -1.1%N/A10.4 $25.12 8/31/20243,640,000 shares $94.20 million -7.1%N/A10.6 $25.88 8/15/20243,920,000 shares $100.98 million -2.5%N/A11.4 $25.76 7/31/20244,020,000 shares $96.56 million -5.2%N/A10.7 $24.02 7/15/20244,240,000 shares $88.19 million +2.2%N/A11 $20.80 6/30/20244,150,000 shares $88.93 million -0.7%N/A10.9 $21.43 6/15/20244,180,000 shares $84.44 million +4.0%N/A10.7 $20.20 5/31/20244,020,000 shares $86.35 million No ChangeN/A10.4 $21.48 5/15/20244,020,000 shares $92.42 million +12.9%N/A9.5 $22.99 4/30/20243,560,000 shares $62.44 million +14.8%N/A9.1 $17.54 4/15/20243,100,000 shares $48.61 million -3.1%N/A8.2 $15.68 3/31/20243,200,000 shares $59.36 million +5.6%N/A7.8 $18.55 3/15/20243,030,000 shares $52.48 million -7.6%N/A7.5 $17.32 2/29/20243,280,000 shares $55.43 million -7.6%N/A7.7 $16.90 2/15/20243,550,000 shares $64.57 million -1.9%N/A7.9 $18.19 1/31/20243,620,000 shares $61.54 million -10.6%N/A7.2 $17.00 1/15/20244,050,000 shares $70.39 million +1.0%N/A7.1 $17.38 12/31/20234,010,000 shares $65.16 million -5.4%N/A7.3 $16.25 12/15/20234,240,000 shares $63.39 million +4.4%N/A7.9 $14.95 11/30/20234,060,000 shares $50.22 million -1.9%N/A7.5 $12.37 11/15/20234,140,000 shares $51.09 million +4.6%N/A7.9 $12.34 10/31/20233,960,000 shares $40.00 million -6.2%N/A7.3 $10.10Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 10/15/20234,220,000 shares $50.85 million +15.9%N/A8.3 $12.05 9/30/20233,640,000 shares $50.27 million +11.0%N/A7.9 $13.81 9/15/20233,280,000 shares $42.44 million +3.5%N/A7.2 $12.94 8/31/20233,170,000 shares $41.88 million +5.3%N/A7.4 $13.21 8/15/20233,010,000 shares $36.93 million -9.6%N/A7.8 $12.27 7/31/20233,330,000 shares $66.20 million +7.8%N/A9.3 $19.88 7/15/20233,090,000 shares $60.63 million +2.0%N/A9.8 $19.62 6/30/20233,030,000 shares $66.96 million +13.1%N/A9.9 $22.10 6/15/20232,680,000 shares $61.16 million +1.1%N/A8.8 $22.82 5/31/20232,650,000 shares $61.88 million +5.6%N/A8.5 $23.35 5/15/20232,510,000 shares $48.84 million +3.7%6.3%8.2 $19.46 4/30/20232,420,000 shares $42.50 million +2.5%6.1%8.8 $17.56 4/15/20232,360,000 shares $46.94 million +10.8%5.9%8 $19.89 3/31/20232,130,000 shares $46.33 million +0.5%5.3%6.6 $21.75 3/15/20232,120,000 shares $45.54 million +10.4%5.4%6.7 $21.48 2/28/20231,920,000 shares $44.66 million +3.2%4.9%6.1 $23.26 2/15/20231,860,000 shares $44.01 million -7.5%4.7%5.8 $23.66 1/31/20232,010,000 shares $47.11 million -13.7%5.1%5.3 $23.44 1/15/20232,330,000 shares $54.85 million -5.7%5.9%6.1 $23.54 12/30/20222,470,000 shares $44.95 million -2.4%6.2%6.6 $18.20 12/15/20222,530,000 shares $47.49 million -17.9%6.4%6.7 $18.77 11/30/20223,080,000 shares $65.20 million +1.7%7.8%8.3 $21.17 11/15/20223,030,000 shares $74.54 million +16.1%7.7%8.5 $24.60 10/31/20222,610,000 shares $61.39 million +1.6%6.6%7.8 $23.52 10/15/20222,570,000 shares $52.15 million +4.5%6.5%8.2 $20.29 9/30/20222,460,000 shares $55.97 million +2.1%6.3%7.5 $22.75 9/15/20222,410,000 shares $62.52 million +2.1%6.1%6.4 $25.94 8/31/20222,360,000 shares $55.72 million -2.9%6.0%6.2 $23.61 8/15/20222,430,000 shares $63.20 million -3.6%6.2%5.8 $26.01 7/31/20222,520,000 shares $48.56 million +12.0%6.4%5.5 $19.27 7/15/20222,250,000 shares $35.80 million +0.9%5.8%4.6 $15.91 6/30/20222,230,000 shares $30.80 million +43.9%5.7%4.5 $13.81 6/15/20221,550,000 shares $21.86 million +3.3%12.0%3.2 $14.10 5/31/20221,500,000 shares $20.58 million +4.9%3.8%3.3 $13.72 5/15/20221,430,000 shares $17.76 million +13.5%3.7%3.2 $12.42 4/30/20221,260,000 shares $15.96 million +18.9%3.2%3.2 $12.67 4/15/20221,060,000 shares $17.96 million +1.9%2.7%2.7 $16.94 3/31/20221,040,000 shares $23.64 million -27.3%2.7%2.8 $22.73 3/15/20221,430,000 shares $30.53 million -22.7%3.7%3.7 $21.35 2/28/20221,850,000 shares $43.48 million -7.5%4.8%4.4 $23.50 2/15/20222,000,000 shares $53.58 million +7.0%5.2%4.7 $26.79 1/31/20221,870,000 shares $55.80 million +13.3%4.8%4.2 $29.84 1/15/20221,650,000 shares $50.89 million -9.8%4.3%3.7 $30.84 12/31/20211,830,000 shares $68.20 million +8.9%4.7%4.3 $37.27 12/15/20211,680,000 shares $58.38 million +0.6%4.3%4.1 $34.75 11/30/20211,670,000 shares $63.73 million +42.7%4.3%4.8 $38.16 11/15/20211,170,000 shares $57.61 million -18.8%3.0%2.2 $49.24 10/29/20211,440,000 shares $76.54 million -8.9%3.8%2.9 $53.15 10/15/20211,580,000 shares $64.67 million -4.8%4.3%3.6 $40.93 9/30/20211,660,000 shares $70.25 million -20.2%4.5%3.8 $42.32Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/15/20212,080,000 shares $99.96 million -16.8%5.6%4.6 $48.06 8/31/20212,500,000 shares $145.90 million +93.8%6.9%5.6 $58.36 8/13/20211,290,000 shares $58.46 million -0.8%3.6%5.3 $45.32 7/30/20211,300,000 shares $60.97 million -9.7%3.6%5.2 $46.90 7/15/20211,440,000 shares $62.71 million +1.4%4.0%5.2 $43.55 6/30/20211,420,000 shares $63.20 million +30.3%3.9%5.1 $44.51 6/15/20211,090,000 shares $43.16 million +35.8%3.0%3.8 $39.60 5/28/2021802,800 shares $26.74 million -0.4%2.3%2.7 $33.31 5/14/2021806,000 shares $23.80 million +20.8%2.3%2.7 $29.53 4/30/2021667,300 shares $23.08 million -7.6%2.3%2.2 $34.59 4/15/2021722,200 shares $24.26 million -27.5%2.5%2.4 $33.59 3/31/2021995,600 shares $35.80 million +28.7%3.4%3.2 $35.96 3/15/2021773,700 shares $29.38 million +20.9%2.7%2.5 $37.97 2/26/2021640,000 shares $24.95 million +10.2%2.2%2.1 $38.99 2/12/2021580,800 shares $24.16 million -5.0%2.0%1.9 $41.59 1/29/2021611,400 shares $23.42 million -12.8%2.1%1.9 $38.31 1/15/2021701,400 shares $29.41 million No Change2.5%2.1 $41.93 BLFS Short Interest - Frequently Asked Questions What is BioLife Solutions' current short interest? Short interest is the volume of BioLife Solutions shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 4,360,000 shares of BLFS short. 9.39% of BioLife Solutions' shares are currently sold short. Learn More on BioLife Solutions' current short interest. What is a good short interest ratio for BioLife Solutions? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLFS shares currently have a short interest ratio of 7.0. Learn More on BioLife Solutions's short interest ratio. Which institutional investors are shorting BioLife Solutions? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLife Solutions: Millennium Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioLife Solutions? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.39% of BioLife Solutions' floating shares are currently sold short. Is BioLife Solutions' short interest increasing or decreasing? BioLife Solutions saw a decrease in short interest in June. As of June 15th, there was short interest totaling 4,360,000 shares, a decrease of 6.8% from the previous total of 4,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioLife Solutions' short interest compare to its competitors? 9.39% of BioLife Solutions' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to BioLife Solutions: Soleno Therapeutics, Inc. (9.72%), Inspire Medical Systems, Inc. (12.02%), PROCEPT BioRobotics Corporation (12.78%), Envista Holdings Corporation (6.08%), LivaNova PLC (4.08%), Warby Parker Inc. (10.21%), NovoCure Limited (5.00%), LeMaitre Vascular, Inc. (6.41%), National Vision Holdings, Inc. (7.40%), Enovis Corporation (10.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short BioLife Solutions stock? Short selling BLFS is an investing strategy that aims to generate trading profit from BioLife Solutions as its price is falling. BLFS shares are trading up $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLife Solutions? A short squeeze for BioLife Solutions occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLFS, which in turn drives the price of the stock up even further. How often is BioLife Solutions' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLFS, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Soleno Therapeutics Short Squeeze Inspire Medical Systems Short Squeeze PROCEPT BioRobotics Short Squeeze Envista Short Squeeze LivaNova Short Squeeze Warby Parker Short Squeeze NovoCure Short Squeeze LeMaitre Vascular Short Squeeze National Vision Short Squeeze Enovis Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLFS) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.